Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

6.12
Delayed Data
As of 4:00pm ET
 -0.15 / -2.39%
Today’s Change
3.50
Today|||52-Week Range
10.89
+14.39%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.27
Today’s open6.12
Day’s range5.89 - 6.21
Volume24,164
Average volume (3 months)15,829
Market cap$499.3M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-467.25%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.05-0.41%
OFIXOrthofix Internation...-0.30-0.84%
CFMSConforMIS Inc+0.15+1.78%
DSCIDerma Sciences Inc+0.05+0.72%
Data as of 4:03pm ET, 01/20/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts


Search for Jobs